AnalystBook Research · Company Intelligence

Evogene Ltd.

EVGNNasdaq

Built from Evogene Ltd.'s own SEC filings · updates as new filings land · every figure links to its source

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score -12.86 distress zone — historically elevated failure riskWatch

Latest filings

  • 6-K · Company announcement (foreign filer)2026-06-16
  • 6-K · Company announcement (foreign filer)2026-06-11
  • 6-K · Company announcement (foreign filer)2026-05-20
  • 6-K · Company announcement (foreign filer)2026-05-18
  • 6-K · Company announcement (foreign filer)2026-04-02
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, every figure source-linked🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask anything about Evogene Ltd., every answer cited🔒
  • The Intelligence Brief — added when Evogene Ltd.'s brief passes our SEC-figure check🔒

Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.